Supporting Aging Through Green Exercise (SAGE)
SAGE
1 other identifier
interventional
72
1 country
1
Brief Summary
Aerobic exercise is an evidence-based approach to mitigate cognitive decline in older adults with mild cognitive impairment (MCI). Emerging evidence suggests that the cognitive benefits of exercise may be enhanced when performed in outdoor, natural settings, as compared to indoor or built settings. Thus, the investigators aim to compare the effects of outdoor versus indoor walking programs on cognitive function among older adults with MCI. Secondary outcomes are motor function, emotional well-being, health-related behaviours, and quality of life. Participants will be randomly assigned to a 12--week, 3x/week program of either outdoor walking on forest trails or indoor walking on a treadmill. A 3-month followup will also be completed after trial completion.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 1, 2021
CompletedFirst Posted
Study publicly available on registry
September 5, 2021
CompletedStudy Start
First participant enrolled
January 19, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 10, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
November 27, 2023
CompletedJanuary 29, 2024
January 1, 2024
1.5 years
September 1, 2021
January 25, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in List Sorting Performance
This is a measure of working memory
Baseline to 12 weeks
Change in Digits Span Forwards and Backwards
This is a measure of working memory.
Baseline to 12 weeks
Secondary Outcomes (18)
Change in NIH Toolbox Cognitive Battery Performance
Baseline to 12 weeks
Change in Digit Symbol Substitute Test
Baseline to 12 weeks
Change in the Short Physical Performance Battery
Baseline to 12 weeks
Change in Timed Up and Go Test
Baseline to 12 weeks
Change in State-Trait Anxiety Inventory
Baseline to 12 weeks and 6 months
- +13 more secondary outcomes
Study Arms (2)
Aerobic Exercise Indoors
ACTIVE COMPARATOREach session will consist of 10 min of warm-up, 40 min of aerobic exercise, and 10 min of cool-down. Aerobic exercise will be progressive and of moderate intensity. During training, each participant will wear a heart rate monitor and will be asked to work initially at approximately 45% of his/her target heart rate (i.e., heart rate reserve (HRR)) and gradually progress to reach the target of 70% of HRR over the 12-week study period. Participants will also subjectively monitor workout intensity using the 20-point Borg's Rating of Perceived Exertion. Participants will walk or jog on treadmills or cycle on stationary bikes in the Exercise Prescription Suite of the Centre for Hip Health and Mobility.
Aerobic Exercise Outdoors
EXPERIMENTALEach session will consist of 10 min of warm-up, 40 min of aerobic exercise, and 10 min of cool-down. Aerobic exercise will be progressive and of moderate intensity. During training, each participant will wear a heart rate monitor and will be asked to work initially at approximately 45% of his/her target heart rate (i.e., heart rate reserve (HRR)) and gradually progress to reach the target of 70% of HRR over the 12-week study period. Participants will also subjectively monitor workout intensity using the 20-point Borg's Rating of Perceived Exertion. participants will walk or jog pre-determined routes in trails of an urban forest (Pacific Spirit Park).
Interventions
Each session will consist of 10 min of warm-up, 40 min of aerobic exercise, and 10 min of cool-down. Aerobic exercise will be progressive and of moderate intensity. During training, each participant will wear a heart rate monitor and will be asked to work initially at approximately 45% of his/her target heart rate (i.e., heart rate reserve (HRR)) and gradually progress to reach the target of 70% of HRR over the 12-week study period. Participants will also subjectively monitor workout intensity using the 20-point Borg's Rating of Perceived Exertion. Participants will walk or jog on treadmills or cycle on stationary bikes in the Exercise Prescription Suite of the Centre for Hip Health and Mobility.
Each session will consist of 10 min of warm-up, 40 min of aerobic exercise, and 10 min of cool-down. Aerobic exercise will be progressive and of moderate intensity. During training, each participant will wear a heart rate monitor and will be asked to work initially at approximately 45% of his/her target heart rate (i.e., heart rate reserve (HRR)) and gradually progress to reach the target of 70% of HRR over the 12-week study period. Participants will also subjectively monitor workout intensity using the 20-point Borg's Rating of Perceived Exertion. Participants will walk or jog pre-determined routes in trails of an urban forest (Pacific Spirit Park)
Eligibility Criteria
You may qualify if:
- achieve a score ≥18/30 and ≤24/30 on the Montreal Cognitive Assessment
- have subjective cognitive impairment based on interview
- have no significant impairment in daily function, as determined by a score ≥6/8 on the Lawton and Brody Instrumental Activities of Daily Living Scale
- no diagnosis of dementia
- aged 65 to 80 years old
- live independently in their own home
- live in the Greater Vancouver area
- read, write, and speak English with acceptable visual and auditory acuity
- are cleared to start a supervised exercise programme based on the Physical Activity Readiness Questionnaire for Everyone
- able to walk independently
- able to provide informed consent
You may not qualify if:
- participating in regular moderate to vigorous intensity aerobic exercise in the last 3 months
- planning to enroll in a concurrent exercise or drug trial targeting cognitive function
- diagnosed with a neurological, cerebrovascular, or psychiatric disease, or other chronic medical condition requiring intensive treatment and monitoring
- have major impairments in eyesight, hearing or motor movements
- have clinically significant neuropathy or musculoskeletal or joint disease
- have a recent traumatic brain injury, including concussions
- are currently using prescribed cognitive intervention or electromagnetic stimulation
- at the time of recruit, indicate they recently (within the last 2 months) or will start taking drugs that significantly alter cognition, movement, or affect, such as cholinesterase inhibitors, anticholinergics, hormone replacement therapy, or antidepressants
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of British Columbia
Vancouver, British Columbia, V5Z1M9, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Teresa Liu-Ambrose, PhD
University of British Columbia
- PRINCIPAL INVESTIGATOR
Matthew Noseworthy, BSc
University of British Columbia
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Assessor will be blinded.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
September 1, 2021
First Posted
September 5, 2021
Study Start
January 19, 2022
Primary Completion
July 10, 2023
Study Completion
November 27, 2023
Last Updated
January 29, 2024
Record last verified: 2024-01